TABLE 2.
Clinical outcomes of patients with SALI.
| Variables | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| Non-aspirin | Aspirin | P value | Non-aspirin | Aspirin | P value | |
| Patients number | 447 | 210 | 148 | 148 | ||
| Length of hospital stay | 8.9 (4.5, 17.0) | 11.0 (6.1, 19.0) | 0.020 | 8.1 (4.0, 14.8) | 12.0 (7.2, 19.1) | <0.001 |
| Length of ICU stay | 3.0 (1.8, 5.8) | 4.0 (2.2, 7.2) | 0.003 | 2.8 (1.8, 5.2) | 4.5 (2.5, 7.7) | <0.001 |
| In-hospital mortality | 147 (32.9) | 58 (27.6) | 0.174 | 43 (29.1) | 35 (23.7) | 0.291 |
| ICU mortality | 129 (28.9) | 40 (19.1) | 0.007 | 37 (25.0) | 21 (14.2) | 0.019 |
| 30-day mortality | 163 (36.5) | 56 (26.7) | 0.013 | 49 (33.1) | 31 (21.0) | 0.018 |
| 90-day mortality | 199 (44.5) | 79 (37.6) | 0.095 | 62 (41.9) | 50 (33.8) | 0.150 |
SALI: Sepsis-associated liver injury; PSM: propensity score matching; ICU: Intensive Care Unit. P value <0.05 is considered statistical significance.